Elbit Imaging Ltd. (EMITF)

OTCMKTS: EMITF · Delayed Price · USD
0.850
+0.050 (6.25%)
May 23, 2024, 11:38 AM EDT - Market closed
Market Cap 9.00M
Revenue (ttm) 88,088
Net Income (ttm) -4.87M
Shares Out 10.59M
EPS (ttm) -0.50
PE Ratio n/a
Forward PE n/a
Dividend $0.01 (1.27%)
Ex-Dividend Date Jun 29, 2023
Volume n/a
Open 0.850
Previous Close 0.800
Day's Range n/a
52-Week Range 0.096 - 1.250
Beta 0.60
Analysts n/a
Price Target n/a
Earnings Date Aug 30, 2012

About EMITF

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 27, 1996
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol EMITF
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

There is no news available yet.